In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21)

Biochimie

Volumn 78, Issue 11-12, 1996, Pages 1067-1073

  Kozu, T ^a   Sueoka, E ^a   Okabe, S ^a   Sueoka, N ^a   Komori, A ^a   Fujiki, H ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Fusion gene; Gene therapy; Hammerhead ribozyme; Leukemia

Indexed keywords

MESSENGER RNA; RIBOZYME;

ACUTE GRANULOCYTIC LEUKEMIA; CONFERENCE PAPER; GENE FUSION; GENE THERAPY; RNA CLEAVAGE;

EID: 0030437754     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(97)86731-4     Document Type: Conference Paper

References (22)

1. 1 Cech TR, Zaug AJ, Grabowski PJ (1981 ) In vitro splicing of the ribosomal RNA precursor of Tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27, 487-496
2. 2 Kruger K, Grabowski PJ, Zaug AJ, Sands J, Gottschling DE, Cech TR (1982) Self-splicing RNA: Autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell 31, 147-157
3. 3 Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857
4. 4 Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55, 599-629
5. 5 Uhlenbeck OC (1987) A small catalytic oligoribonucleotide. Nature 328, 596-600
6. 6 Haseloff J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334, 585-591
7. 7 Kiehntopf M, Esquivel EL, Brach MA, Hermann F (1995) Clinical applications of ribozymes. Lancet 345, 1027-1031
8. 8 Christoffersen RE, Marr JJ (1995) Ribozymes as human therapeutic agents. J Med Chem 38, 2023-2037
9. 9 Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88, 10431-10434
10. 10 Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80, 1825-1831
11. 11 Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N, Ohki M (1993) Junctions of the AML1/MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 82, 1270-1276
12. 12 Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M (1993) The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 12, 2715-2721
13. 13 Kozu T, Sueoka E, Okabe S, Sueoka N, Komori A, Fujiki H (1996) Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA. J Cancer Res Clin Oncol 122, 254-256
14. 14 Heidenreich O, Benseler F, Fahrenholz A, Eckstein F (1994) High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidine nucleosides and phosphorothioates. J Biol Chem 269, 2131-2138
15. 15 Taylor NR, Kaplan BE, Swiderski P, Li H, Rossi JJ (1992) Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo. Nucleic Acids Res 20, 4559-4565
16. 16 Hendry P, McCall MJ, Santiago FS, Jennings PA (1992) A ribozyme with DNA in the hybridizing arms displays enhanced cleavage ability. Nucleic Acids Res 20, 5737-5741
17. 17 Hendry P, McCall MJ (1995) A comparison of the in vitro activity of DNA-armed and all-RNA hammerhead ribozymes. Nucleic Acids Res 23, 3928-3936
18. 18 Pachuk CJ, Yoon K, Moelling K, Coney LR (1994) Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences. Nucleic Acids Res 22, 301-307
19. 19 Snyder DS, Wu Y, Wang JL, Rossi JJ, Swiderski P, Kaplan BE, Forman SJ (1993) Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood 82, 600-605
20. 20 Kiehntopf M, Brach MA, Licht T, Petschauer S, Karawajew L, Kirschning C, Herrmann F (1994) Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells. EMBO J 13, 4645-4652
21. 21 Pieken WA, Olsen DB, Benseler F, Aurup H, Eckstein F (1991) Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes. Science 253, 314-317
22. 22 Heidenreich O, Pieken W, Eckstein F (1993) Chemically modified RNA: approaches and applications. FASEB J 7, 90-96